 |
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2020, vol. 26, issue4
Subject Area: Medicine
-
DOI: 10.5272/jimab.2020264.3363
Published online: 06 October 2020
Review article
J of IMAB. 2020 Oct-Dec;26(4):3363-3367
INFLUENZA INFECTION AS TRIGGER FOR ACUTE MYOCARDIAL INFARCTION AND STROKE
Darina Miteva
,
Clinic of Pneumology and Phthysiatry, UMHAT St. Marina, Department of Pulmonology and Allergology, Faculty of Medicine, Medical University, Varna, Bulgaria.
ABSTRACT:
Influenza affects millions of patients every year. The manifestations vary from mild respiratory symptoms to severe pulmonary and extra-pulmonary complications and even death. Recent scientific evidence has been accumulating that influenza infection can trigger acute myocardial infarction and stroke. Both diseases are the leading causes of death worldwide, and the recognition of the risk factors is crucial for adequate prevention. This article reviews the pathogenetic links between influenza and the development of myocardial infarction and stroke. It presents the incidence, timing and outcome of these acute cardiovascular events after influenza infection and the role of vaccination for their prevention. The aim of the review is to focus the attention of medical practitioners on the association between influenza and cardiovascular events in order to improve the prevention and management of high-riskpatients.
Keywords: respiratory infections, pneumonia, influenza, acute myocardial infarction, stroke,
- Download FULL TEXT /PDF 504 KB/
Please cite this article as: Miteva D. Influenza infection as trigger for acute myocardial infarction and stroke. J of IMAB. 2020 Oct-Dec;26(4):3363-3367. DOI: 10.5272/jimab.2020264.3363
Correspondence to: Dr Darina Miteva, PhD, Clinic of Pneumology and Phthysiatry, UMHAT “St. Marina”; 1, Hristo Smirnenski Blvd., Varna 9010, Bulgaria; E-mail: dari.miteva@abv.bg
REFERENCES:
1. Influenza (Seasonal). WHO. 6 November 2018. [Internet]
2. The top 10 causes of death. WHO. 24 May 2018. [Internet]
3. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation. 2003; 107(5):762-68.
4. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006; 1: 297–329.
5. Aliberti S, Ramirez JA. Cardiac diseases complicating community-acquired pneumonia. CurrOpin Infect Dis. 2014 Jun;27(3):295-301
6. Kreutz RP, Bliden KP, Tantry US, Gurbel PA. Viral respiratory tract infections increase platelet reactivity and activation: an explanation for the higher rates of myocardial infarction and stroke during viral illness. J Thromb Haemost. 2005 Sep;3(9):2108-9.
7. Kreutz RP, Tantry US, Bliden KP, Gurbel PA. Inflammatory changes during the ‘common cold’ are associated with platelet activation and increased reactivity of platelets to agonists. Blood Coagul Fibrinolysis. 2007 Dec;18(8):713-8.
8. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis. 2010 Feb;10(2):83-92.
9. Corrales-Medina VC, Musher DM,Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet. 2013 Feb 9;381(9865):496-505.
10. BazazR, Marriott HM, Francis SE, Dockrell DH. Mechanistic links between acute respiratory tract infections and acute coronary syndromes. J Infect. 2013 Jan;66(1):1-17.
11. Miller E, Elkind MSV. Infection and Stroke: an Update on Recent Progress. Curr Neurol Neurosci Rep. 2016 Jan;16(1):2. [PubMed] [Crossref]
12. Collins S.Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Reports. 1932; 47:2159–2179.
13. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol. 2004 Sep 1;160(5):492-502.
14. Nunes B, Viboud C, Machado A, Ringholz C, Rebelo-de-Andrade H, Nogueira P, Miller M. Excess Mortality Associated with Influenza Epidemics in Portugal, 1980 to 2004. PLoS One. 2011 Jun 21; 6(6): e20661.
15. Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal Influenza Infections and Cardiovascular Disease Mortality. JAMA Cardiol. 2016 Jun 1;1(3):274-81. [PubMed] [Crossref]
16. Madjid M, Miller CC, Zarubaev VV Marinich IG, Kiselev OI, Lobzin YV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J. 2007 May;28(10):1205-10.
17. Foster ED, Cavanaugh JE, Haynes WG, Yang M, Gerke AK, Tang F, Polgreen PM. Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects. Epidemiol Infect. 2013 Apr;141(4):735-44
18. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004 Dec 16;351(25):2611-8.
19. Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J. 2008 Jan;29(1):96-103.
20. Elkind MS, Carty CL, O’Meara ES, Lumley T, Lefkowitz D, Kronmal RA, Longstreth WT Jr. Hospitalization for infection and risk of acute ischemic stroke: the Cardiovascular Health Study. Stroke. 2011 Jul;42(7):1851-6.
21. Zurrú MC, Alonzo C, Brescacín L, Romano M, Cámera LA, Waisman G, et al. Recent respiratory infection predicts atherothrombotic stroke: case-control study in a Buenos Aires healthcare system. Stroke. 2009 Jun;40(6):1986-90.
22. Ruane L, Buckley T, Hoo SYS, Hansen PS, McCormack C, Shaw E, et al. Triggering of acute myocardial infarction by respiratory infection. Intern Med J. 2017 May;47(5):522-529. [Crossref]
23. Warren-Gash C, Blackburn R, Whitaker H, McMenamin J, Hayward AC. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Respir J. 2018 Mar 29;51(3):1701794. [PubMed] [Crossref]
24. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, KarnauchowT, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018 Jan 25;378(4):345-353. [PubMed] [Crossref]
25. Blackburn RM, Zhao H, Pebody R, Hayward AC, Warren-Gash C. Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015. Clin Infect Dis. 2018 Jan 18; 67(1):8-17. [Crossref]
26. Boehme AK, Luna J, Kulick ER, Kamel H, Elkind MSV. Influenza like illness as a trigger for ischemic stroke. Ann ClinTransl Neurol. 2018 Mar 14; 5(4): 456-63. [Crossref]
27. Fullerton HJ, Hills NK, Elkind MS, Dowling MM, Wintermark M, Glaser CA et al. Infection, vaccination, and childhood arterial ischemic stroke: Results of the VIPS study. Neurology. 2015 Oct 27; 85(17):1459-66. [Crossref]
28. Vejpongsa P, Kitkungvan D, Madjid M, Charitakis K, Anderson HV, Arain S, et al. Outcomes of Acute Myocardial Infarction in Patients with Influenza and Other Viral Respiratory Infections. Am J Med. 2019 Oct;132(10):1173-1181. [PubMed] [Crossref]
29. Putot A, Chague F, Manckoundia P, Cottin Y, Zeller M. Post-Infectious Myocardial Infarction: New Insights for Improved Screening. J Clin Med. 2019 Jun; 8(6): 827. [Crossref]
30. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions [FLUVACS] study. Euro Heart J. 2004 Jan;25(1):25-31. [PubMed] [Crossref]
31. Wu HH, Chang YY, Kuo SC, Chen YT. Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study. PLoS One. 2019 Jul 1;14(7):e0219172. [Crossref]
32. Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013 Oct 23;310(16):1711-20.
33. Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015 May 5;(5):CD005050. [PubMed] [Crossref]
34. MacIntyre CR, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, et al. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart. 2013 Dec;99(24):1843–8.
35. Barnes M, Heywood AE, Mahimbo A, Rahman B1, Newall AT, Macintyre CR. Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart. 2015 Nov;101(21):1738-47. [Crossref]
36. MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016 Dec 15;102(24):1953-56. [Crossef]
37. Grau AJ, Fischer B, Barth C, Ling P, Lichy C, Buggle F. Influenza vaccination is associated with a reduced risk of stroke. Stroke. 2005 Jul; 36 (7):1501–6.
38. Lin HC, Chiu HF, Ho SC, Yang CY. Association of influenza vaccination and reduced risk of stroke hospitalization among the elderly: a population-based case–control study. Int J Environ Res Public Health. 2014 Apr 2; 11(4):3639–49.
39. Lavallee PC, Labreuche J, Fox KM, Lavados P, Mattle H, Steg PG, et al. Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke. Neurology. 2014 May 27;82(21):1905-13.
40. Lee KR, Bae JH, Hwang IC, Kim KK, Suh HS, Ko KD. Effect of Influenza Vaccination on Risk of Stroke: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2017; 48(3-4):103-110. [Crossref]
41. Christiansen CF, Thomsen RW, Schmidt M, Pedersen L, Sørensen HT. Influenza Vaccination and 1-year Risk of Myocardial Infarction, Stroke, Heart Failure, Pneumonia, and Mortality Among Intensive Care Unit Survivors Aged 65 Years or Older: A Nationwide Population-Based Cohort Study. Intensive Care Med. 2019 Jul;45(7):957-967. [PubMed] [Crossref]
42. Bermudez-Fajardo A, Oviedo-Orta E. Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice. Atherosclerosis. 2011 Jul; 217(1):97-105.
43. Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, et al. Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism. Vaccine. 2014 Nov 12;32(48):6569-75.
44. Korsun N, Angelova S, Georgieva I. [Influenza.] medinfo.bg. 2016 Jun;14(10):18-22. [in Bulgarian] [Internet].
Received: 07 November 2019
Published online: 06 October 2020